When COVID-19 harms cancer patients, men fare worse, study shows
In a new study, researchers found that men with COVID-19 and cancer run a greater risk for severe symptoms and death than women with...
This new cancer drug may effectively treat COVID-19
In a recent study at Virginia Commonwealth University, researchers found that an experimental cancer drug called AR-12 could inhibit the COVID-19 virus from infecting...
New discovery may help stop breast cancer’s deadly spread
In a new study, researchers found a gene responsible for the spread of triple-negative breast cancer to other parts of the body—a process called...
Scientists develop breakthrough blood test for brain cancer
In a new study, researchers found that genetic mutations that promote the growth of the most common type of brain tumors can be accurately...
Cancer scientists discover new salivary glands in humans
In a new study, researchers have discovered salivary glands in a previously unknown location.
This is potentially great news for patients with head and neck...
New vaccine may prevent many types of cancer, study finds
In a recent study at The Translational Research Institute, researchers found a new cancer vaccine has the potential to treat a variety of blood...
How Tobacco is a top risk factor for bladder cancer
Your bladder probably isn’t your favorite topic of conversation, but knowing when to talk to your doctor about it is crucial to your health.
If...
Vitamin D supplements may lower your risk of developing advanced cancer
In a new study, researchers found that taking vitamin D supplements may reduce the risk of developing advanced cancer.
The research was conducted by a...
This depression drug may stop cancer growth
In a new study, researchers found that the antidepressant sertraline inhibits the growth of cancer cells.
It targes a metabolic addiction that allows different types...
This drug could boost survival in people with head and neck cancer
When first- and second-line treatments have been exhausted, few options remain for patients with advanced head and neck cancer.
A new phase 2 clinical trial...